Skip to content

Quantify the mesenchymal population and the osteogenic differentiation of bone marrow cells

Quantify the mesenchymal population and the osteogenic differentiation of bone marrow cells - bone marrow compensition

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41207
Enrollment
10
Registered
2014-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthopedic differentiation of stem cells

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients - in need of an autologous bone graft harvested of the (anterior or posterior) iliac crest for orthopaedic reason; - understand study proposal and sign informed consent; - > 18 years old

Exclusion criteria

Exclusion criteria: Subjects: - participating in other studies - suffering from an autoimmune disease - suffering from an infection - suffering from a malignancy - receiving or received chemotherapy / other bone marrow suppression medicine

Design outcomes

Primary

MeasureTime frame
Avarage number of stem cells available in a bone marrow aspirate and the different cell typesin %.

Secondary

MeasureTime frame
Number of stem cells with bone or vascular generating potentials (through: CD34, CD45, CD90, CD105, CD146, CD271 markers) Colony forming potentials of stem cells (through CFU-F analysis) Genexpressie of the osteoprogenitors (through PCR analyse) Other baseline parameters will be noted to detect potential confounders: sex, smoking, current diets, age and body weight. Study parameters will be compared between patients and also to the existing literature.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)